ALBANY, N.Y. -- A local cancer patient, whose treatments were jeopardized by the shutdown, boarded a plane for the National Institute of Health in Maryland on Monday and returned to the Capital Region on Tuesday.
Robert Duncan is one of only four people alive who have a rare type of cancer, and his entry into a clinical trial was put on hold because of the shutdown.
After failing to get in touch with his local leaders, NEWS10 ABC's Marty Kasper took his concerns to his congressional representatives, and Duncan got the word last week that he would be able to take part.
Duncan's fight paid off Monday as he boarded a plane bound for Maryland. Doctors at the NIH have given
him potentially life saving medication that isn't available outside of the clinical trial. It's treatment he hopes others in the same
condition have the opportunity to have access to.
"This holds so much promise this drug, in the fact
that there are other people out there who could utilize it. Without it they may die. They're certainly in a fragile condition
right now, and I pray that they will be
able to get an opportunity as well," he said.
Duncan will return to Maryland every four weeks, and he'll meet with doctor's locally every week to track his condition.